Insufficient scRNA-seq data for expression of CDK3 at single-cell level.
Insufficient scRNA-seq data for expression of CDK3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 897.19 | 21 / 21 | 19% | 0.30 | 94 / 504 |
| uterus | 100% | 1305.44 | 170 / 170 | 15% | 0.21 | 69 / 459 |
| ovary | 100% | 1242.18 | 180 / 180 | 13% | 0.17 | 55 / 430 |
| pancreas | 100% | 657.19 | 327 / 328 | 13% | 0.19 | 23 / 178 |
| lung | 100% | 1190.94 | 578 / 578 | 10% | 0.14 | 121 / 1155 |
| prostate | 100% | 2157.43 | 245 / 245 | 10% | 0.13 | 51 / 502 |
| kidney | 100% | 1179.52 | 89 / 89 | 5% | 0.07 | 48 / 901 |
| brain | 98% | 528.24 | 2578 / 2642 | 8% | 0.10 | 53 / 705 |
| thymus | 100% | 1733.98 | 653 / 653 | 5% | 0.06 | 30 / 605 |
| liver | 100% | 1334.37 | 226 / 226 | 5% | 0.07 | 20 / 406 |
| intestine | 100% | 987.61 | 966 / 966 | 5% | 0.06 | 25 / 527 |
| esophagus | 100% | 650.84 | 1442 / 1445 | 4% | 0.05 | 7 / 183 |
| breast | 100% | 1062.40 | 459 / 459 | 3% | 0.04 | 32 / 1118 |
| stomach | 100% | 733.29 | 359 / 359 | 2% | 0.02 | 6 / 286 |
| skin | 100% | 1022.65 | 1806 / 1809 | 2% | 0.02 | 8 / 472 |
| adrenal gland | 100% | 805.40 | 258 / 258 | 0% | 0.00 | 1 / 230 |
| adipose | 100% | 981.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1745.40 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 533.35 | 1319 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 514.73 | 874 / 929 | 0% | 0 | 0 / 0 |
| heart | 93% | 402.58 | 805 / 861 | 0% | 0 | 0 / 0 |
| muscle | 43% | 112.62 | 348 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.07 | 2 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.08 | 3 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0006974 | Biological process | DNA damage response |
| GO_0010468 | Biological process | regulation of gene expression |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0051301 | Biological process | cell division |
| GO_0008283 | Biological process | cell population proliferation |
| GO_0045746 | Biological process | negative regulation of Notch signaling pathway |
| GO_0010389 | Biological process | regulation of G2/M transition of mitotic cell cycle |
| GO_0045023 | Biological process | G0 to G1 transition |
| GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
| GO_0000307 | Cellular component | cyclin-dependent protein kinase holoenzyme complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0030332 | Molecular function | cyclin binding |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0004693 | Molecular function | cyclin-dependent protein serine/threonine kinase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | CDK3 |
| Protein name | Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3) Cyclin dependent kinase 3 |
| Synonyms | CDKN3 |
| Description | FUNCTION: Serine/threonine-protein kinase that plays a critical role in the control of the eukaryotic cell cycle; involved in G0-G1 and G1-S cell cycle transitions. Interacts with CCNC/cyclin-C during interphase. Phosphorylates histone H1, ATF1, RB1 and CABLES1. ATF1 phosphorylation triggers ATF1 transactivation and transcriptional activities, and promotes cell proliferation and transformation. CDK3/cyclin-C mediated RB1 phosphorylation is required for G0-G1 transition. Promotes G1-S transition probably by contributing to the activation of E2F1, E2F2 and E2F3 in a RB1-independent manner. . |
| Accessions | ENST00000586261.2 ENST00000425876.6 ENST00000448471.3 K7EJ83 Q00526 |